• Latest Posts

LG Chem renews license triggering $2M payment to Avacta

Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy

GSK Raises Eyebrows in Checkpoint Inhibitor Megadeal with iTeos

BMS’s Cancer Trial Showcases Potential for Checkpoint Inhibitors

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

Innate’s Cancer Immunotherapy Combo Beats Standard Treatment Twofold

ADVERTISEMENT

Replimune’s €85M IPO set to Boost Oncolytic Immunotherapy Pipeline

Interview 24 Jul 2018

Meet the Dutch Scientists who Invented Keytruda, “The President’s Drug”

Massive Series B Funding Could Bring Belgian Immuno-oncology Treatments Into the Clinic

Genmab and Janssen Suffer Combination Therapy Setback

Boehringer Offers €1Bn for New Checkpoint Inhibitor from a French Biotech

Danish Biotech Collaborates With US Merck on Combination Therapy for Lung Cancer

ADVERTISEMENT